With the investigation of the pathogenic mutations of patients and the efficacy of AEDs, interestingly, we found that epilepsy patients having pathogenic mutations in the genes associated with voltage-gated sodium channels (i.e., SCN8A, SCN2A) are well controlled with clinical AEDs without any serious side effects. The gene discussed is SCN8A; the disease is epilepsy.